Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The thigh: slower absorption with fewer side effects The front of the thigh is the second most popular injection site, and it has advantages that make it the preferred choice for a significant subset of GLP-1 users
The current generation of GLP-1 receptor agonists includes: Semaglutide (weekly subcutaneous injection or oral formulation) Liraglutide (daily subcutaneous injection) Tirzepatide (dual GLP-1/GIP receptor agonist, weekly subcutaneous injection) Each of these GLP-1 agents carries a distinct pharmacological profile, and the optimal choice depends on a patients clinical history, metabolic risk factors, and therapeutic goals a determination best made in consultation with a physician experienced in metabolic and longevity medicine
You don't have to go to bed after this therapy
Everything included $89.50 /month Billed monthly GLP-1 therapy with licensed oversight, transparent pricing, and support built for sustainable weight loss
US$ 28.56
US$ 26.62
US$ 21.52
US$ 25.91
